• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统医学、肝纤维化、肠道菌群:它们之间有联系吗?——一篇叙述性综述。

Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review.

机构信息

Department of Traditional Chinese Medicine, Graduate School, Hunan University of Chinese Medicine, Changsha, China.

Department of Infection, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.

出版信息

Ann Palliat Med. 2021 Apr;10(4):4846-4857. doi: 10.21037/apm-20-2129. Epub 2021 Apr 1.

DOI:10.21037/apm-20-2129
PMID:33832318
Abstract

This paper aims to analyze how intestinal flora regulates liver fibrosis pathogenesis and to evaluate the regulatory effect of traditional Chinese medicine (TCM) on the intestinal flora, providing new insights into liver fibrosis treatment. Destruction of the intestinal microbiome can lead to liver fibrosis development, accelerating the intestinal microbiome's disruption. TCM can effectively regulate the intestinal flora, helping prevent and treat liver fibrosis. This review discusses the mechanisms behind intestinal flora changes in liver fibrosis and how TCM can regulate these changes. We searched PubMed, the Wanfang database, and CNKI for "liver fibrosis", "intestinal microflora", and "intestinal microbiota" and reviewed the retrieved literature. We detail the prevention and treatment options for liver fibrosis though the use of TCM in regulating intestinal flora. We also highlight the influence of the intestinal flora on liver fibrosis and present the research regarding the prevention and treatment of liver fibrosis using TCM. We also describe the effects of TCM on the intestinal flora. TCM can effectively regulate the intestinal flora to prevent and treat liver fibrosis through the liver-intestine axis.

摘要

本文旨在分析肠道菌群如何调节肝纤维化发病机制,并评估中药对肠道菌群的调节作用,为肝纤维化的治疗提供新的思路。肠道微生物组的破坏可导致肝纤维化的发展,加速肠道微生物组的破坏。中药能有效调节肠道菌群,有助于预防和治疗肝纤维化。本综述讨论了肝纤维化中肠道菌群变化的机制以及中药如何调节这些变化。我们检索了 PubMed、万方数据库和中国知网的“肝纤维化”、“肠道微生物群”和“肠道微生物组”,并对检索到的文献进行了综述。我们详细介绍了通过调节肠道菌群用中药预防和治疗肝纤维化的方法。我们还强调了肠道菌群对肝纤维化的影响,并介绍了利用中药防治肝纤维化的研究。我们还描述了中药对肠道菌群的影响。中药能有效调节肠道菌群,通过肝肠轴预防和治疗肝纤维化。

相似文献

1
Traditional Chinese medicine, liver fibrosis, intestinal flora: is there any connection?-a narrative review.传统医学、肝纤维化、肠道菌群:它们之间有联系吗?——一篇叙述性综述。
Ann Palliat Med. 2021 Apr;10(4):4846-4857. doi: 10.21037/apm-20-2129. Epub 2021 Apr 1.
2
Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine.肠道菌群:中药研究的关键角色。
Am J Chin Med. 2021;49(2):237-268. doi: 10.1142/S0192415X21500130. Epub 2021 Feb 20.
3
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
4
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer.中药、肠道菌群与结直肠癌的三角关系。
Med Res Rev. 2024 Mar;44(2):539-567. doi: 10.1002/med.21989. Epub 2023 Sep 3.
5
Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal flora.考虑将中药作为辅助疗法,通过调节肠道菌群来治疗慢性便秘。
Biosci Trends. 2024 Jun 6;18(2):127-140. doi: 10.5582/bst.2024.01036. Epub 2024 Mar 25.
6
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives.中医药与癌症肠道菌群相互作用:现状与展望。
Pharmacol Res. 2024 May;203:107148. doi: 10.1016/j.phrs.2024.107148. Epub 2024 Mar 22.
7
Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.肠道大肠杆菌及相关功能障碍作为中医药治疗呼吸传染性疾病的潜在靶点。
J Ethnopharmacol. 2023 Sep 15;313:116381. doi: 10.1016/j.jep.2023.116381. Epub 2023 Mar 20.
8
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier.中药影响肠道菌群和肠道屏障的机制。
Front Cell Infect Microbiol. 2022 Apr 28;12:863779. doi: 10.3389/fcimb.2022.863779. eCollection 2022.
9
An overview of traditional Chinese medicine affecting gut microbiota in obesity.中医对肥胖症中肠道微生物群影响的概述。
Front Endocrinol (Lausanne). 2023 Mar 1;14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023.
10
Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.中药中的植物化学物质可以通过抑制 NLRP3 和 XOD 活性来调节肠道菌群,从而治疗痛风。
J Pharm Pharmacol. 2022 Jul 15;74(7):919-929. doi: 10.1093/jpp/rgac024.

引用本文的文献

1
Correlation between differences in the intestinal flora structure and Chinese medicine evidence in patients with Wilson disease-related liver fibrosis analyzed via high-throughput sequencing technology.基于高通量测序技术分析肝豆状核变性相关肝纤维化患者肠道菌群结构差异与中医证候的相关性
Biosci Microbiota Food Health. 2025;44(2):146-159. doi: 10.12938/bmfh.2024-081. Epub 2024 Dec 11.
2
Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance.清肝抑脾胶囊通过下调TGF-β1/Smad2/3信号通路和改善肠道微生物群失衡来改善大鼠肝纤维化。
Front Pharmacol. 2025 Jan 24;16:1525914. doi: 10.3389/fphar.2025.1525914. eCollection 2025.
3
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.
中药对肠道微生物群及微生物-肠-肝轴的调节作用
Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.
4
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.中药和膳食化合物对肝纤维化中肠道微生物群调节作用的研究综述
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
5
Kangxianling formula attenuates renal fibrosis by regulating gut microbiota.抗纤灵方通过调节肠道微生物群减轻肾纤维化。
Eur J Med Res. 2024 Mar 18;29(1):183. doi: 10.1186/s40001-024-01778-8.
6
Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect.连翘酯苷A-透明质酸复合乳源外泌体的制备及其抗肝纤维化作用
Mater Today Bio. 2023 Sep 16;23:100804. doi: 10.1016/j.mtbio.2023.100804. eCollection 2023 Dec.
7
Aqueous extract of alleviates hepatic fibrosis by suppressing hepatic stellate cell activation through inhibiting Stat3 signaling.[提取物名称]的水提取物通过抑制Stat3信号传导来抑制肝星状细胞活化,从而减轻肝纤维化。 (你提供的原文中“Aqueous extract of ”后面缺少具体提取物名称)
Front Pharmacol. 2023 Jun 13;14:1101703. doi: 10.3389/fphar.2023.1101703. eCollection 2023.
8
Scutellarein regulates the PTEN/AKT/NFκB signaling pathway to reduce pirarubicin related liver inflammation.汉黄芩素通过调控 PTEN/AKT/NFκB 信号通路减轻蒽环类药物相关肝损伤的炎症反应。
Int J Mol Med. 2023 Jul;52(1). doi: 10.3892/ijmm.2023.5258. Epub 2023 May 26.
9
Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial.鳖甲煎丸对乙型肝炎肝硬化/肝纤维化患者肠道菌群的影响:一项随机、双盲、对照试验。
Chin J Integr Med. 2023 Sep;29(9):771-781. doi: 10.1007/s11655-023-3542-2. Epub 2023 May 24.
10
Network pharmacology and molecular docking reveal zedoary turmeric-trisomes in Inflammatory bowel disease with intestinal fibrosis.网络药理学和分子对接揭示莪术在炎症性肠病伴肠纤维化中的三萜类成分。
World J Clin Cases. 2022 Aug 6;10(22):7674-7685. doi: 10.12998/wjcc.v10.i22.7674.